Access Statistics for Heidi L. Williams

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A toolkit of policies to promote innovation 0 0 0 45 0 0 10 92
A toolkit of policies to promote innovation 0 0 1 365 1 7 33 1,417
Accelerating Innovation Ecosystems: The Promise and Challenges of Regional Innovation Engines 0 1 2 36 0 4 31 89
Advance Market Commitments for Vaccines Against Neglected Diseases: Estimating Costs and Effectiveness 0 0 0 13 1 8 21 110
Advance Market Commitments for Vaccines Working Paper and Spread Sheet 0 0 0 88 1 1 10 554
Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness 0 0 0 56 0 2 11 325
Advanced purchase commitments for a malaria vaccine: estimating costs and effectiveness 0 0 0 2 0 2 18 67
Do firms underinvest in long-term research? Evidence from cancer clinical trials 0 0 0 50 3 5 19 140
Do fixed patent terms distort innovation? Evidence from cancer clinical trials 0 0 0 50 0 4 15 254
Dynamic Scoring: A Progress Report on Why, When, and How 0 0 1 6 0 2 14 25
Estimating Marginal Returns to Medical Care: Evidence from At-Risk Newborns 0 0 1 66 0 3 27 351
Estimating the Economic and Budgetary Effects of Research Investments 0 0 2 6 0 0 15 27
How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome 0 0 1 63 2 5 27 201
How Do Patents Affect Research Investments? 0 0 0 64 1 3 18 128
Innovation: Market Failures and Public Policies 1 2 3 79 3 14 51 254
Intellectual Property Rights and Innovation: Evidence from Health Care Markets 0 0 0 67 0 4 11 108
Intellectual Property Rights and Innovation: Evidence from the Human Genome 0 1 1 52 0 1 11 248
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs 0 0 0 0 0 3 4 20
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs 0 0 0 45 0 3 15 74
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs 0 0 0 0 0 2 6 60
Missing Markets for Innovation: Evidence from New Uses for Existing Drugs 1 3 34 34 3 7 50 50
Optimal Subsidies for Prevention of Infectious Disease 0 0 0 5 1 4 12 40
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases 0 0 0 19 2 5 21 80
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases 0 0 0 17 1 3 11 43
Patents and Research Investments: Assessing the Empirical Evidence 0 0 0 50 1 6 12 81
Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments 0 0 0 30 0 2 22 79
Paying on the margin for medical care: Evidence from breast cancer treatments 0 0 0 22 0 3 8 53
Place-Based Drivers of Mortality: Evidence from Migration 0 0 1 56 1 5 17 125
Private and Public Investments in Biomedical Research 0 0 0 10 0 4 6 33
Representation and Extrapolation: Evidence from Clinical Trials 0 0 1 23 0 2 15 46
Screening and Selection: The Case of Mammograms 0 0 0 11 0 3 14 75
Sources of Geographic Variation in Health Care: Evidence from Patient Migration 0 0 3 94 1 2 32 246
Targeting Precision Medicine: Evidence from Prenatal Screening 0 0 2 20 0 2 11 25
The More We Die, The More We Sell? A Simple Test of the Home-Market Effect 0 0 0 23 3 4 15 104
The More We Die, The More We Sell? A Simple Test of the Home-Market Effect 0 0 0 0 0 0 5 64
The More We Die, The More We Sell? A Simple Test of the Home-Market Effect* 0 0 0 0 0 1 13 18
The NBER Orange Book Dataset: A User’s Guide 0 0 0 23 1 8 20 54
The Wandering Scholars: Understanding the Heterogeneity of University Commercialization 0 0 2 19 1 7 26 59
What Drives Risky Prescription Opioid Use? Evidence from Migration 0 0 1 57 0 7 32 171
Who Profits from Patents? Rent-Sharing at Innovative Firms 0 0 0 26 0 3 15 76
Who Profits from Patents? Rent-Sharing at Innovative Firms 0 0 2 47 3 5 25 257
Why is Infant Mortality Higher in the US than in Europe? 0 0 0 64 0 7 19 123
Total Working Papers 2 7 58 1,803 30 163 768 6,446

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Toolkit of Policies to Promote Innovation 0 2 4 132 2 15 61 455
Accelerating Innovation Ecosystems: The Promise and Challenges of Regional Innovation Engines 1 3 11 14 3 11 50 68
Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases 0 0 2 144 0 2 15 482
Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness 0 1 1 36 0 5 16 236
Creating Markets for Vaccines (Innovations Case Discussion: International AIDS Vaccine Initiative) 0 0 0 9 0 3 7 69
Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials 0 0 2 25 2 7 25 220
Estimating Marginal Returns to Medical Care: Evidence from At-risk Newborns 0 2 5 179 3 13 52 814
How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome 0 0 1 45 3 9 26 369
How Do Patents Affect Research Investments? 0 0 0 20 1 4 10 95
Incentivizing Innovation: Adding to the Tool Kit 0 0 0 14 2 7 21 123
Innovation Inducement Prizes: Connecting Research to Policy 0 0 0 0 0 2 10 162
Intellectual Property Rights and Innovation: Evidence from Health Care Markets 0 0 2 9 1 1 15 113
Intellectual Property Rights and Innovation: Evidence from the Human Genome 0 0 0 253 1 10 40 1,317
Internalizing Externalities: Designing Effective Data Policies 0 0 0 6 0 1 9 38
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs 0 0 0 12 0 4 13 146
Optimal vaccine subsidies for endemic diseases 0 0 0 4 0 3 31 41
Patents and Research Investments: Assessing the Empirical Evidence 0 0 0 28 1 2 18 248
Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments 0 0 0 10 0 5 9 147
Place-Based Drivers of Mortality: Evidence from Migration 0 3 4 32 4 14 31 211
Private and Public Investments in Biomedical Research 0 0 0 6 0 1 6 35
Report of the Editor, Journal of Economic Perspectives 0 0 0 0 0 0 2 5
Report of the Editor: Journal of Economic Perspectives 0 0 0 0 0 2 4 8
Screening and Selection: The Case of Mammograms 0 0 2 18 0 3 20 146
Sources of Geographic Variation in Health Care: Evidence From PatientMigration 1 2 4 110 3 7 27 513
The More We Die, The More We Sell? A Simple Test of the Home-Market Effect 0 0 2 25 0 1 18 231
The NBER Orange Book Dataset: A user’s guide 0 0 0 0 1 5 12 19
The Role of Hospital Heterogeneity in Measuring Marginal Returns to Medical Care: A Reply to Barreca, Guldi, Lindo, and Waddell 0 0 0 29 0 2 16 169
Want to speed up scientific progress? First understand how science policy works 0 1 1 8 1 3 15 31
Who Profits from Patents? Rent-Sharing at Innovative Firms 0 0 0 46 0 4 35 312
Why Is Infant Mortality Higher in the United States Than in Europe? 0 0 1 25 3 9 21 202
Total Journal Articles 2 14 42 1,239 31 155 635 7,025
1 registered items for which data could not be found

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accelerating Innovation Ecosystems: The Promise and Challenges of Regional Innovation Engines 0 0 0 6 2 7 21 51
Comment on "Aging and Death under a Dollar a Day" 0 0 0 6 1 3 10 55
Comment on "Income, Aging, Health and Well-Being around the World: Evidence from the Gallup World Poll" 0 0 0 5 0 2 7 53
Comment on "Is Decentralized Iron Fortification a Feasible Option to Fight Anemia Among the Poorest?" 0 0 0 3 0 1 5 32
Estimating the Economic and Budgetary Effects of Research Investments 0 0 1 7 2 2 14 27
Incentivizing Innovation: Adding to the Tool Kit 0 0 0 84 0 2 13 279
Intellectual Property Rights and Innovation: Evidence from Health Care Markets 0 0 0 11 0 2 8 99
Total Chapters 0 0 1 122 5 19 78 596

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-07-10